Lorazepam Dosing for Anxiety and Panic Disorder
For anxiety disorders, initiate lorazepam at 2-3 mg/day divided into 2-3 doses (typically 0.5-1 mg per dose), with the largest dose at bedtime; for panic disorder specifically, mean effective doses are approximately 7 mg/day divided throughout the day. 1, 2
Standard Dosing Algorithm
Initial Dosing for Anxiety
- Start with 2-3 mg/day in divided doses (e.g., 1 mg twice daily or 0.5-1 mg three times daily), with the largest dose before bedtime 1
- The usual therapeutic range is 2-6 mg/day, though some patients may require 1-10 mg/day 1
- For acute anxiety episodes, use 0.5-1 mg orally every 4-6 hours as needed, with a maximum of 4 mg/24 hours 3
Panic Disorder-Specific Dosing
- Lorazepam demonstrates comparable efficacy to alprazolam for panic disorder at a mean daily dose of 7 mg/day 2
- This is substantially higher than typical anxiety dosing and reflects the more severe nature of panic disorder 2
- Both lorazepam and other benzodiazepines show rapid onset of antipanic effects that are maintained over 7-8 months without dose escalation 4
Dose Titration Strategy
- Increase dosage gradually to minimize adverse effects 1
- When higher doses are needed, increase the evening dose first before adjusting daytime doses 1
- This approach capitalizes on the sedative effects during sleep while maintaining daytime function 1
Special Population Adjustments
Elderly or Debilitated Patients
- Reduce initial dose to 1-2 mg/day in divided doses (e.g., 0.25-0.5 mg per dose) 1
- Maximum dose should not exceed 2 mg/24 hours in elderly patients 5, 3
- Elderly patients face significantly higher risks of falls, cognitive decline, and paradoxical agitation (occurring in approximately 10% of patients) 3, 6
Hepatic Impairment
- For advanced liver disease, reduce initial dose to 0.25 mg orally 2-3 times daily 3
Treatment Duration and Discontinuation
Duration Considerations
- Benzodiazepines should be reserved for short-term use or when psychological treatments are refused/unavailable 3
- Regular use leads to tolerance, addiction risk, depression, and cognitive impairment 3
- Efficacy is maintained for 7-8 months without dose escalation in panic disorder, though long-term use carries dependency risks 4
Discontinuation Protocol
- Use gradual taper to reduce withdrawal risk 1
- If withdrawal reactions develop, pause the taper or increase back to the previous dose level, then decrease more slowly 1
- Discontinuation difficulties occur in a considerable number of panic disorder patients but can be minimized with proper tapering 4
Administration Details
Oral Concentrate Formulation
- Mix with liquid (water, juice, soda) or semi-solid food (applesauce, pudding) using the calibrated dropper 1
- Consume the entire mixture immediately; do not store for future use 1
- Tablets can be used sublingually when swallowing is difficult 5, 3
Critical Safety Considerations
Contraindications
- Severe pulmonary insufficiency, severe liver disease, and myasthenia gravis (except in moribund patients) 3
- Do not combine with other sedatives due to significantly increased respiratory depression risk 3
- Extreme caution required with concomitant high-dose olanzapine due to reported fatalities 3
Common Pitfalls to Avoid
- Underdosing in panic disorder: The mean effective dose (7 mg/day) is substantially higher than typical anxiety dosing (2-3 mg/day) 2
- Using as monotherapy for delirium-related agitation, which may worsen confusion 6
- Abrupt discontinuation rather than gradual taper 1
- Failing to reduce doses in elderly patients, leading to preventable adverse events 5, 3
Comparative Efficacy Evidence
Lorazepam demonstrates equivalent antipanic efficacy to alprazolam, with both drugs showing significant improvement throughout 6-week trials 2. The primary difference is dosing: lorazepam requires approximately 7 mg/day versus 3 mg/day for alprazolam to achieve comparable effects 2. Both medications are well-tolerated aside from sedative effects, and clonazepam may offer advantages as a first-line agent due to its longer duration of action 4.